| Document |
Document Title |
|
WO/2023/009610A1 |
The application discloses methods useful for the synthesis of racemic, scalemic, and chiral alpha-tocotrienol quinone, including synthetic intermediates and methods for making said synthetic intermediates.
|
|
WO/2023/272571A1 |
A compound as represented by formula 1 that has an inhibitory effect on the novel coronavirus 2019-nCoV; a racemate or an optical isomer thereof, a solvate thereof, or a pharmaceutically acceptable salt thereof; and the use thereof in th...
|
|
WO/2023/275324A1 |
The present invention relates to a process for preparing at least one schweinfurthin chosen from schweinfurthin G of formula (SW-G), schweinfurthin K of formula (SW-K) and schweinfurthin R of formula (SW-R), characterized in that it comp...
|
|
WO/2022/268840A1 |
Described herein are methods for making intermediates in the production of fragrance ingredients starting from β-farnesene. In particular, methods for making acetylmethylfarnesol and hydroxy-farnesylacetone are described. Methods for ma...
|
|
WO/2022/267081A1 |
Disclosed is a green and efficient method for catalyzing butene to prepare epoxybutane with organic small molecules. The method uses butene as a raw material, an organic solvent and a catalyst are added, isobutyraldehyde is used as a co-...
|
|
WO/2022/263437A1 |
In a first aspect, the present invention relates to a shutdown method for a process for preparing an olefin oxide comprising a normal run stage, wherein the normal run stage comprises providing olefin, hydrogen peroxide and organic solve...
|
|
WO/2022/238145A1 |
The integrated plant for making propene oxide comprises a unit (1) for producing hydrogen peroxide by an anthraquinone process, which comprises a hydrogenator (3), an oxidizer (4) and an extraction column, and a unit (2) for making prope...
|
|
WO/2022/230745A1 |
The present invention provides a compound which is represented by formula (1). (In formula (1), each of R1, R2, R3 and R4 independently represents a hydrogen atom, a polymerizable functional group having 1 to 50 carbon atoms or an alkyl ...
|
|
WO/2022/231172A1 |
The present invention relates to: a multifunctional epoxy compound obtained by modifying two or more epoxide functional groups on terminal portions of liquid crystal molecules synthesized by bonding multiple thermotropic liquid crystal m...
|
|
WO/2022/224820A1 |
The present invention provides: a compound represented by formula I, formula I', formula II, or formula II'; and a composition that is for regulating circadian rhythm and that contains said compound or an Agrocybe erebia culture.
|
|
WO/2022/213996A1 |
Disclosed is a compound comprising at least one structural unit represented by formulas (1)-(4). The compound comprises at least one cross-linkable group. The compound has a relatively large molar extinction coefficient and high fluoresc...
|
|
WO/2022/210324A1 |
Provided are: a resin composition including a precursor of a cyclized resin and a base generator, wherein the base generated by the base generator is a base that cyclizes within the same molecule and becomes a tertiary amine, and the bas...
|
|
WO/2022/189559A1 |
The present invention relates to a process for preparing an olefin oxide from a reaction mixture stream in an epoxidation reactor R, wherein R contains z active reaction tubes T(i) arranged in parallel, z≥2, i=1...z, wherein each T(i) ...
|
|
WO/2022/158462A1 |
Provided are a glycidyl (meth)acrylate composition wherein a phenolic polymerization inhibitor included therein does not readily deteriorate and the glycidyl (meth)acrylate composition can be stably preserved for a long time period, as w...
|
|
WO/2022/158463A1 |
The present invention provides: a glycidyl (meth)acrylate composition that can be stably stored for long periods of time without a phenolic polymerization inhibitor that is included in the composition being readily degraded; and a method...
|
|
WO/2022/155779A1 |
A preparation process for epichlorohydrin. The process involves the following steps: (1) a chlorination reaction, wherein glycerol and hydrogen chloride gas are transported to a reaction kettle for a chlorination reaction; and (2) a cycl...
|
|
WO/2022/149468A1 |
Provided is a bisphenol AF-type diglycidyl ether represented by formula (1), wherein an abundance ratio of the bisphenol AF-type diglycidyl ether having n≥1 is less than 30 mass%. (In formula (1), R1-R8 are each independently a hydroge...
|
|
WO/2022/148456A1 |
Pharmaceutical compositions comprising a chemotherapeutic agent based on a β-substituted β-amino acid derivative are disclosed. The pharmaceutical compositions include a β-substituted β-amino acid derivative and a cyclodextrin deriva...
|
|
WO/2022/133544A1 |
Cannabidiol (CBD) cannabinoids and CBD cannabinoid analogues with, inter alia, antimicrobial activity, synthetic methods for the preparation thereof and medical uses and formulations containing same.
|
|
WO/2022/134657A1 |
Disclosed in the present invention are a daphnane-type diterpenoid resistant to prostate cancer, and a preparation method therefor. The inventor has found by means of study that daphnane-type diterpenoid compounds as represented by formu...
|
|
WO/2022/140518A1 |
A composition comprising a non-cationic amine epoxide adduct is disclosed, along with methods of making the same. Use of a composition comprising a non-cationic amine epoxide adduct on textiles and paper, particularly woven textiles, tis...
|
|
WO/2022/134675A1 |
Disclosed are a zirconium-based gold catalyst for a propylene epoxidation reaction and a preparation method therefor. The catalyst uses zirconium-based materials as the support, including ZrO2and a zirconium silicon molecular sieve. Afte...
|
|
WO/2022/135564A1 |
Provided are a system and method for preparing epoxy chloropropane. In the present invention, the epoxy chloropropane product and water vapor are evaporated from a reaction system in the form of an azeotrope by means of water vapor strip...
|
|
WO/2022/122975A1 |
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, for use as a drug, especially as an antibiotic. The present invention also relates to a pharmaceutical composition c...
|
|
WO/2022/114138A1 |
Provided is a novel method for producing a (1R,2R,3R,5R,6R)-2-amino-6-fluoro-3-[(4-fluorophenyl)methoxy
]bicycle[3.1.0]hexane-2,6-dicarboxylic acid. This production method is characterized by relying on the conversion from a compound rep...
|
|
WO/2022/107139A1 |
The present invention is directed to a process for the preparation of a hydrazine derivative by reaction of the corresponding oxirane with hydrazine, that uses as only solvent toluene. The process provides excellent yields and purities a...
|
|
WO/2022/105250A1 |
A porous polymer, and a catechol-derived porous polymer and a catechol-derived porous polymer-supported high-spin monatomic iron catalyst prepared on the basis of the porous polymer. Further disclosed are a method for preparing the catal...
|
|
WO/2022/083082A1 |
The present invention provides a method for preparing bicalutamide intermediate 2, comprising the following steps: dissolving N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methacrylamide in a lower fatty acid ester solvent, successively adding...
|
|
WO/2022/064320A1 |
Catalytic process for producing alkylene epoxide, selected between ethylene oxide or propylene oxide, from the corresponding alkylene carbonate, selected between ethylene carbonate or propylene carbonate, comprising the decomposition rea...
|
|
WO/2022/057931A1 |
The present invention provides a continuous synthesis process and a continuous reaction device for epichlorohydrin. The continuous synthesis process comprises placing hydrogen peroxide, methanol, chloropropene, and a catalyst into a reac...
|
|
WO/2022/052067A1 |
Disclosed are a metal organic framework material MIL-125, a preparation method therefor, and the use thereof. The metal organic framework material MIL-125 is a round-cake-shaped crystal block; and the external specific surface area there...
|
|
WO/2022/040788A1 |
Anti -cancer, chemotherapeutic, or antiproliferative compositions comprising, as an active ingredient, a compound of formula (I0), or a salt, or prodrug thereof: and an anti-cancer, chemotherapeutic, or antiproliferative compound (A) or ...
|
|
WO/2022/032945A1 |
The present application relates to the technical field of photolithography, and specifically relates to a bisphenol A derivative, a preparation method therefor, and an application thereof in photolithography. The compound provided has a ...
|
|
WO/2022/030622A1 |
The present invention provides a method which can produce an intermediate of an azole derivative at lower cost than an existing production method. The method is for producing a compound represented by general formula (IV) and includes a ...
|
|
WO/2022/007388A1 |
The present invention relates to the field of propylene oxide preparation, and discloses a method for preparing propylene oxide by means of the direct epoxidation of propylene. The method comprises: under propylene epoxidation reaction c...
|
|
WO/2022/007897A1 |
Disclosed are a method and culture medium for performing an in vivo treatment on ovaries of mammals including humans or performing in vitro culturing on ex vivo ovaries or ovarian tissue by means of using 4-vinylcyclohexene diepoxide. Th...
|
|
WO/2022/007387A1 |
The present invention relates to the field of epoxypropane preparation, and in particular to a method and system for preparing epoxypropane by directly epoxidizing propylene. The method comprises: under a propylene epoxidation reaction c...
|
|
WO/2022/002380A1 |
The present invention primarily relates to novel processes for preparing cis-cedrandiol. Moreover, the present invention relates to a novel compound of formula (X), as described herein, preferably of formula X' or - particularly preferab...
|
|
WO/2022/003278A1 |
The present invention relates to a compound having the following formula (I): wherein: - T is selected from the group consisting of CN+-O-, CH = NOH and CHO; - A is a C6-C14 arenediyl ring, optionally substituted with one or more hydroca...
|
|
WO/2022/003280A1 |
The invention relates to a rubber composition based on at least one diene elastomer, at least one reinforcing filler, at least one crosslinking agent and at least one compound having formula (I), optionally already grafted onto said elas...
|
|
WO/2021/256361A1 |
A coloring composition comprising a coloring agent, a compound having an ethylenically unsaturated bond-including group, and a compound having an epoxy group, wherein the compound having an epoxy group includes a compound Ep having a gro...
|
|
WO/2021/247667A1 |
A method for making a monomer includes reacting an alkanol-substituted phenol with epihalohydrin in the presence of a phase transfer catalyst at a temperature of 50 °C or lower to produce a first intermediate product. The method further...
|
|
WO/2021/226845A1 |
The present application provides a chelating agent, a cleaning agent and a method for preparing the chelating agent. The chelating agent has a general structural formula as shown in formula (I), wherein: R1, R2, R3 and R4 are alkyl group...
|
|
WO/2021/225833A1 |
Provided herein are processes for synthesizing Mcl-1 inhibitors and intermediates such as compound Z that can be used to prepare them. In particular, provided herein are processes for synthesizing compound A1, and salts or solvates there...
|
|
WO/2021/216670A1 |
The present disclosure provides compounds of Formula I for use in the treatment of medical disorders by the inhibition of human epididymal protein 4 (HE4).
|
|
WO/2021/208951A1 |
Disclosed is a β-diketone cerium (IV) compound of formula (I). The compound has a wide absorption band, is suitable for near ultraviolet-visible region curing as a photoinitiator, and has a high sensitiveness, while also having the adva...
|
|
WO/2021/204193A1 |
The present invention belongs to the field of medicaments or nutraceutical products, and specifically relates to a compound represented by the following general formula (I), or an enantiomer, diastereomer, salt, ester, prodrug, solvate, ...
|
|
WO/2021/200511A1 |
A compound represented by formula (1). (In the formula, R1 and R3 each independently represent a hydrogen atom or a methyl group, R2 represents a C1-10 alkyl group, a C1-10 alkoxy group, a halogen atom, a benzoyl group capable of having ...
|
|
WO/2021/194380A1 |
The invention relates to a method for producing a crystalline form of calcium cis-2,3-epoxysuccinate using a seed crystal that is a crystalline form of calcium cis-2,3-epoxysuccinate, the crystals of which belong to the Р21/n space grou...
|
|
WO/2021/194384A1 |
The invention relates to the field of producing metal carboxylates. In particular, the present invention relates to the crystalline form of calcium cis-2,3-epoxysuccinate (salt of 2,3-epoxy-1,4-butanedioic acid) and a method for the prod...
|
